The Bear Cave

Share this post
Problems at Fulgent Genetics (FLGT)
thebearcave.substack.com

Problems at Fulgent Genetics (FLGT)

Problems at Fulgent Genetics (FLGT)

Edwin Dorsey
Jan 7, 2021
2
Share this post
Problems at Fulgent Genetics (FLGT)
thebearcave.substack.com

Fulgent Genetics (NASDAQ: FLGT — $1.62 billion) has rallied around 400% since March as the company has successfully pivoted to creating coronavirus test kits. The market is giving the company an excessive ~$1.3 billion valuation boost on what will be around a ~$550 million one-time benefit from the pandemic. In addition, a series of related party transa…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2022 Edwin Dorsey
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing